| 1 |
/m/0jxtqt9
|
Survanta (Abbott Laboratories), manufactured drug form of Beractant, 25mg/mL beractant suspension, NDC 0074-1040
/lang/en
|
2012-10-13T04:07:45.0000Z
|
| 2 |
/m/0jxtqt9
|
NDA020032
|
2012-06-10T09:02:17.0000Z
|
| 3 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc7
cvt
|
2012-06-10T09:02:15.0001Z
|
| 4 |
/m/0jxtqt9
|
false
|
2012-06-10T09:02:09.0003Z
|
| 5 |
/m/0jxtqt9
|
0074-1040
|
2012-06-10T09:01:44.0002Z
|
| 6 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc12
cvt
|
2012-06-10T09:01:17.0005Z
|
| 7 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc8
cvt
|
2012-06-10T09:01:16.0000Z
|
| 8 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/articlekey_0j98c98
|
2012-06-10T09:01:11.0000Z
|
| 9 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc9
cvt
|
2012-06-10T09:01:09.0002Z
|
| 10 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc6
cvt
|
2012-06-10T09:01:03.0001Z
|
| 11 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc3
cvt
|
2012-06-10T09:00:52.0001Z
|
| 12 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc13
cvt
|
2012-06-10T09:00:51.0002Z
|
| 13 |
/m/0jxtqt9
|
1991-07-01
|
2012-06-10T09:00:46.0001Z
|
| 14 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc11
cvt
|
2012-06-10T09:00:38.0000Z
|
| 15 |
/m/0jxtqt9
|
/m/0hqtw_5
Beractant 25 suspension
|
2012-06-10T09:00:32.0001Z
|
| 16 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc4
cvt
|
2012-06-10T09:00:01.0000Z
|
| 17 |
/m/0jxtqt9
|
/m/02gkg4
Abbott Laboratories
|
2012-06-10T08:59:55.0003Z
|
| 18 |
/m/0jxtqt9
|
false
|
2012-06-10T08:59:48.0000Z
|
| 19 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc0
cvt
|
2012-06-10T08:59:44.0001Z
|
| 20 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc5
cvt
|
2012-06-10T08:59:38.0000Z
|
| 21 |
/m/0jxtqt9
|
/m/0j4tkgf
Survanta
|
2012-06-10T08:59:35.0000Z
|
| 22 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc2
cvt
|
2012-06-10T08:59:32.0003Z
|
| 23 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc10
cvt
|
2012-06-10T08:59:28.0000Z
|
| 24 |
/m/0jxtqt9
|
/m/09c7w0
United States of America
|
2012-06-10T08:59:18.0000Z
|
| 25 |
/m/0jxtqt9
|
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ef9e3a5-fc39-4ae1-0dad-6b47a1684635
|
2012-06-10T08:59:14.0005Z
|
| 26 |
/m/0jxtqt9
|
/m/083jv
White
|
2012-06-10T08:59:10.0004Z
|
| 27 |
/m/0jxtqt9
|
/base/medicaldrugs/fda_load/cvt_f835d500f0b8c95b1bcc08cfe50731fc1
cvt
|
2012-06-10T08:59:06.0000Z
|
| 28 |
/m/0jxtqt9
|
2012-02-22
|
2012-06-10T08:59:04.0001Z
|
| 29 |
/m/0jxtqt9
|
Survanta 25 suspension
/lang/en
|
2012-06-04T23:48:56.0000Z
|
| 30 |
/m/0jxtqt9
|
/business/consumer_product
|
2012-06-04T23:46:56.0000Z
|
| 31 |
/m/0jxtqt9
|
/medicine/manufactured_drug_form
|
2012-06-04T23:44:48.0003Z
|
| 32 |
/m/0jxtqt9
|
mdf_0074_1040_abbott_laboratories_S866O45PIG_25_0mg_mL_suspension
/base/medicaldrugs/fda_load
|
2012-06-04T23:44:47.0002Z
|
| 33 |
/m/0jxtqt9
|
/boot/all_permission
|
2012-06-04T23:44:47.0001Z
|